BioPorto Statistics
Total Valuation
BioPorto has a market cap or net worth of 95.70 million. The enterprise value is 92.24 million.
Market Cap | 95.70M |
Enterprise Value | 92.24M |
Important Dates
The next estimated earnings date is Friday, August 15, 2025.
Earnings Date | Aug 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 429.66M |
Shares Outstanding | n/a |
Shares Change (YoY) | +13.12% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 452.53M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 19.17 |
PB Ratio | 15.94 |
P/TBV Ratio | 16.03 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -7.75 |
EV / Sales | 17.53 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | -7.18 |
Financial Position
The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.25.
Current Ratio | 2.23 |
Quick Ratio | 1.87 |
Debt / Equity | 0.25 |
Debt / EBITDA | n/a |
Debt / FCF | -0.12 |
Interest Coverage | -134.77 |
Financial Efficiency
Return on equity (ROE) is -197.60% and return on invested capital (ROIC) is -110.28%.
Return on Equity (ROE) | -197.60% |
Return on Assets (ROA) | -75.41% |
Return on Invested Capital (ROIC) | -110.28% |
Return on Capital Employed (ROCE) | -182.52% |
Revenue Per Employee | 103,986 |
Profits Per Employee | -247,968 |
Employee Count | 48 |
Asset Turnover | 0.47 |
Inventory Turnover | 2.67 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.91% in the last 52 weeks. The beta is 0.93, so BioPorto's price volatility has been similar to the market average.
Beta (5Y) | 0.93 |
52-Week Price Change | +30.91% |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 47.74 |
Average Volume (20 Days) | 46,655 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioPorto had revenue of 4.99 million and -11.90 million in losses. Loss per share was -0.03.
Revenue | 4.99M |
Gross Profit | 3.23M |
Operating Income | -12.77M |
Pretax Income | -13.06M |
Net Income | -11.90M |
EBITDA | -12.66M |
EBIT | -12.77M |
Loss Per Share | -0.03 |
Balance Sheet
The company has 4.76 million in cash and 1.48 million in debt, giving a net cash position of 3.28 million.
Cash & Cash Equivalents | 4.76M |
Total Debt | 1.48M |
Net Cash | 3.28M |
Net Cash Per Share | n/a |
Equity (Book Value) | 6.00M |
Book Value Per Share | 0.01 |
Working Capital | 4.71M |
Cash Flow
In the last 12 months, operating cash flow was -12.60 million and capital expenditures -248,922, giving a free cash flow of -12.85 million.
Operating Cash Flow | -12.60M |
Capital Expenditures | -248,922 |
Free Cash Flow | -12.85M |
FCF Per Share | n/a |
Margins
Gross margin is 64.64%, with operating and profit margins of -255.86% and -238.46%.
Gross Margin | 64.64% |
Operating Margin | -255.86% |
Pretax Margin | -261.58% |
Profit Margin | -238.46% |
EBITDA Margin | -253.73% |
EBIT Margin | -255.86% |
FCF Margin | n/a |
Dividends & Yields
BioPorto does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -13.12% |
Shareholder Yield | n/a |
Earnings Yield | -12.44% |
FCF Yield | -13.43% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
BioPorto has an Altman Z-Score of 3.08.
Altman Z-Score | 3.08 |
Piotroski F-Score | n/a |